At the completion of this activity, the participant will be able to: 

• Discuss the current guidelines and recommendations regarding asthma and COPD pharmacotherapy management, in adults.
• Describe initial assessment and patient considerations that may help aid in the selection of specific treatment options
• Evaluate new treatment options for asthma and COPD and their place in therapy
• Highlight the importance of the pharmacy team on enhancing and monitoring adherence to asthma and COPD pharmacotherapy.
• List suggestions patients with asthma and COPD could follow to prevent infection with COVID-19

Program

Some content in program.

Instructor

Some content in instructor.